Cite
A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice
MLA
Qianqian Ma, et al. “A Novel Fusion Protein Consisting of Anti-ANGPTL3 Antibody and Interleukin-22 Ameliorates Diabetic Nephropathy in Mice.” Frontiers in Immunology, vol. 13, Dec. 2022. EBSCOhost, https://doi.org/10.3389/fimmu.2022.1011442.
APA
Qianqian Ma, Xiaozhi Hu, Fangyu Liu, Zhonglian Cao, Lei Han, Kaicheng Zhou, Yu Bai, Yuting Zhang, Yanyang Nan, Qianying Lv, Jia Rao, Tao Wu, Xue Yang, Haidong He, Dianwen Ju, & Hong Xu. (2022). A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1011442
Chicago
Qianqian Ma, Xiaozhi Hu, Fangyu Liu, Zhonglian Cao, Lei Han, Kaicheng Zhou, Yu Bai, et al. 2022. “A Novel Fusion Protein Consisting of Anti-ANGPTL3 Antibody and Interleukin-22 Ameliorates Diabetic Nephropathy in Mice.” Frontiers in Immunology 13 (December). doi:10.3389/fimmu.2022.1011442.